newsfilter
← Latest News
Business Wire·

Gossamer Bio Appoints Greg Ciongoli to Board of Directors

Gossamer Bio, Inc. (NASDAQ:GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary